Atlas Trials

Role of FDG PET, Immune and Hypoxic Marker in NSCLC

Clinical trial NCT02519062 · COMPLETED

Trial details

NCT number
NCT02519062
Sponsor
Istituto Clinico Humanitas
Status
COMPLETED
Study type
OBSERVATIONAL
Carcinoma, Non-Small-Cell Lung
Start date
2014-12-01
Primary completion
2018-12-01
Enrollment
130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.